August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Jan 20, 2025, 02:44

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL

Raul Cordoba, Chair of Community Stakeholder Committee at European Hematology Association (EHA), shared an article by Aisling Barrett on X:

“Hematology Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology: Good Practice Paper British Journal of Haematology.”

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Authors: Aisling Barrett, et al.

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL

Raúl Córdoba Mascuñano, is a specialist in hematology and hemotherapy. He is the Chair of Community Stakeholder Committee at European Hematology Association (EHA) and Coordinator of the Lymphoma Unit and Associate Chief of Hematology Department at Jiménez Díaz Foundation. He is the principal investigator for numerous clinical trials for non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia and other chronic lymphoproliferative syndromes. He is a member of the ethical review board at his current workplace.